Figures & data
Figure 1. Sample selection flowchart for patients with MDD treated with vilazodone or other SSRIs between 2010 and 2012. * The date of the earliest prescription claim on or after September 1, 2011, for citalopram, escitalopram, fluoxetine, paroxetine, sertraline, or vilazodone, whichever occurred first, was defined as the index date (with a 12-month wash-out period prior), and the antidepressant filled on that date was defined as the index drug. † Patients did not use any second-generation antidepressant or antipsychotic other than the index drug within 2 weeks after the index date. Second-generation antidepressants included SSRIs, SNRIs, bupropion, nefazodone, trazodone, and mirtazapine. ‡ Patients receiving fluvoxamine as the index drug were excluded from the analysis due to small sample size. MDD, major depressive disorder; SNRI, serotonin and norepinephrine re-uptake inhibitor; SSRI, selective serotonin re-uptake inhibitor.
